During the past decade, Fundación Sanatorio Güemes conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 4 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundación Sanatorio Güemes" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Fundación Sanatorio Güemes" are "COVID-19" (1 trials), "Metastatic Renal Cell Carcinoma" (1 trials), "Nonalcoholic Steatohepatitis (NASH) With Fibrosis" (1 trials), "Renal Cell Carcinoma" (1 trials) and "Type 2 Diabetes Mellitus" (1 trials). Many other conditions were trialed in "Fundación Sanatorio Güemes" in a lesser frequency.

Most popular intervention types in "Fundación Sanatorio Güemes" are "Drug" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Baricitinib" (1 trials), "Elafibranor" (1 trials), "Insulin Degludec" (1 trials) and "LY3209590" (1 trials). Other intervention names were less common.

The vast majority of trials in "Fundación Sanatorio Güemes" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Fundación Sanatorio Güemes". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Fundación Sanatorio Güemes, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Fundación Sanatorio Güemes, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".